Slide 1: FY2024 (March 2025) Earnings Supplementary Materials
2025 3 CYBERDYNE 2025 5 15
Slide 2: CYBERDYNE
CYBERDYNE
Slide 3: FY2024 Consolidated Results Summary (IFRS)
2025 3 - (IFRS ) ( : ) FY2023 FY2024 4,354 4,384 + 31 + 0.7% 1,433 793 + 640 - 2,018 926 + 1,092 - 1,141 879 + 262 - ( ) 1,476 577 + 899 - EMEA ( ) +198 ( +185 +12) 4,384 APAC +65 ( +31 +34) ( RHG ) +65 ( 27 +92) + 31 + 0.7% ( LeyLine(25 2 ) 3 ) 297 ( 320 +23) ( RHG ) +339 ( 211 , 550 ) 793 +93 ( 91
Slide 4: Results by Segment (RHG)
- / RHG ( : ) FY2023 FY2024 1,762 2,024 + 263 + 14.9% ( ) 818 (46%) 939 (46%) + 121 (0pt) + 14.8% 1,646 1,711 + 65 + 3.9% ( ) 552 ( 34%) 219 ( 13%) + 333 (+ 21pt) - 946 649 297 31.4% ( ) 197 ( 21%) 249 ( 38%) 53 ( 17pt) - RD 2,087 1,396 + 691 - 4,354 4,384 + 31 + 0.7% (IFRS ) ( ) 2,018 ( 46%) 926 (
Slide 5: Revenue by Region: EMEA, APAC, AMER
EMEA ( ), APAC ( ) RHG ( : ) FY2024 EMEA APAC AMER ( FY2023) 947 477 562 39 2,024 +263 (946) (280) (468) (68) (1,762) (+15%) 129 56 1,526 1,710 +65 (137) (55) - (1,453) (1,646) (+4%) 243 406 649 297 (373) (573) - - (946) ( 31%) 1,319 939 562 1,565 4,384 +31 (1,457) (908) (468) (1,521) (4,354) (+0.7%
Slide 6: HAL Revenue by Product
- HAL ( ) HAL ( : ) FY2024 ( FY2023) HAL 372 617 990 (333) (517) (850) HAL 165 - 165 (163) (163) HAL 88 155 243 (90) (100) (190) HAL 105 213 318 (114) (95) (209) HAL 38 - 38 (46) (46) (CL02 ) 75 - 75 (139) (139) Acoustic X 103 93 196 (60) (103) (164) 947 1,078 2,024 (946) (816) (1,762)
Slide 7: CYBERDYNE
CYBERDYNE
Slide 8: Society 5.0/5.1
Society Society Society Society Society 5.0/5.1 1.0 2.0 3.0 4.0
Slide 9: AI and IT Technology Convergence
Ditty k * Al Cybernics " FINDA) Al Al Ditty b ER IRR? Al FIRST ImPACT SIP
Slide 10: Product Lineup
ib Type ability te Medical HAL Single Joint Type Flexible product that can Cleaning Robot HAL Lumbar Type fo! ‘Autonomous robe i Well-being @R product that the next level supports both ‘Transportation Robot Autonomous robot that can BPO - Sei kSeHEA LE Medial HAL Single Joint Well-being A product th
Slide 11: Pre-Hospital, Hospital, Post-Hospital
Pre-Hospital Hospital Post-Hospital
Slide 12: edt
edt Seer eter
Slide 13: RAO RBE
RAO RBE PBRCOSE OY s-yamcemens ER/NILATPOMIS RIROATO
Slide 14: Slide 14
Slide 15: LED Biophotonics
|) BIOPHOTONIGS SINGIN LICH Ta MEeE SCIENCES — > LEDS tieip to Pi Diseased Tissue
Slide 16: CYBERDYNE
CYBERDYNE
Slide 17: Strategic Innovation Program (SIP)
(SIP) 1) 2) ( ) HCPS ( ) 3) HCPS 4)
Slide 18: HCPS
RAE OK BARRIO ae SDH C Be +NOUSH HAY BNIB OING? BABOK?+BRCoHmaMKA> zi Po Bi TN (Pe<X—’T)) BX AbDS-WERY” Zp RNY <BUER RMSE NORBY RID RRL aK a ORRNENY 91 ROT” OVCRUMEREPORAAT RQ HIN PBR ORR —LO KM? im KX wer KEP | <PRRIC ORE ERS PINOLE pS ea) HRY BROOK UEZUBROMEVER iy sip (BRB AS" PNA OLX RED <PR AIK
Slide 19: CYBERDYNE
CYBERDYNE
Slide 20: EU, EMEA, APAC Expansion; HTLV-1 HAM
HTLV-1 HAM HTLV-1 HAM EU EMEA APAC
Slide 21: HTLV-1 HAM
Qereerarwe 2024/5 HTLV-1
Slide 22: G-BA
G-BA 2023/01 2023/03 2023/09 2024/11 CRO G-BA (Federal Joint Committee, ) §137e SGB V Trial Regulation: : G-BA CRO: (Contract Research Organization)
Slide 23: CYBERDYNE
CYBERDYNE
Slide 24: / / /
/ / /
Slide 25: Slide 25
Slide 26: HAL news coverage
HAL 14 Socso urged to build three new rehabilitation centres in five years ‘Singapore. Balan,
Slide 27: https://www.ntu.edu.tw/spotlight/2024/2301_20240918.html
https://www.ntu.edu.tw/spotlight/2024/2301_20240918.html
Slide 28: Slide 28
Slide 29: JICA and HAL
) fisg ok mann DAING HRB Tq} asVE 23R3 be< aya PXHHEA Se teed Zitou RERIDKALERS | EoBoocolke” 5] pie EN BOHOR| ee we] Or meay ze (b] MUCBEPEBIN/ EY QUES CRW | Ee L Vk-aW) Sn’ | POOR BERR | INA POmeiam| m<A Tl SN TRUER | Bboy’ A—DOMMBR DER | pug YER [r<] SHO mLAOD AN WECNSIOY YX —| SBS J REX POR | TH
Slide 30: Qoreerorve
Qoreerorve